Low-Dose Radiation Therapy for Benign Musculoskeletal Disorders
Tarita O. Thomas(Northwestern University), Austin N. Kirschner(Vanderbilt University Medical Center), Bobby N. Koneru(Loyola University Chicago), Lisa Deloch(Friedrich-Alexander-Universität Erlangen-Nürnberg), Austin P.H. Dove(Tennessee Oncology), Richard Shaffer(Bupa Cromwell Hospital)
Cited by 3
Related Papers
Volumetric Modulated Arc Therapy for Delivery of Prostate Radiotherapy: Comparison With Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy
|International Journal of Radiation Oncology*Biology*Physics|2008|532
Volumetric Modulated Arc Therapy Improves Dosimetry and Reduces Treatment Time Compared to Conventional Intensity-Modulated Radiotherapy for Locoregional Radiotherapy of Left-Sided Breast Cancer and Internal Mammary Nodes
|International Journal of Radiation Oncology*Biology*Physics|2009|365
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
|Annals of Oncology|2018|252
A Comparison of Volumetric Modulated Arc Therapy and Conventional Intensity-Modulated Radiotherapy for Frontal and Temporal High-Grade Gliomas
|International Journal of Radiation Oncology*Biology*Physics|2009|153
Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation
|British Journal of Radiology|2015|117